Zealand Pharma (ZLDPF) Income Statement
Zealand Pharma Income Statement
Last quarter (Q2 2026), Zealand Pharma's total revenue was $4.49B, a decrease of 50.58% from the same quarter last year. In Q2, Zealand Pharma's net income was $3.92B. See Zealand Pharma’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 9.21B | $ 62.69M | $ 342.79M | $ 103.99M | $ 292.57M | |
| $ 9.19B | $ 54.82M | $ 323.61M | $ 73.28M | $ 173.75M | |
| $ 2.03B | $ 1.33B | $ 895.85M | $ 920.59M | $ 1.22B | |
| Depreciation and Amortization | $ 27.37M | $ 25.85M | $ 25.09M | $ 117.96M | $ 25.12M |
| $ 7.18B | $ -1.02B | $ -651.58M | $ -797.63M | $ -729.68M | |
| $ 7.16B | $ -1.27B | $ -572.24M | $ -816.60M | $ -1.05B | |
| $ -154.79M | $ 188.76M | $ -136.63M | $ -134.89M | $ 25.43M | |
| $ 7.00B | $ -1.08B | $ -708.87M | $ -972.04M | $ -1.03B | |
| $ 6.46B | $ -1.08B | $ -703.74M | $ -965.61M | $ -1.02B | |
| Per Share Metrics | |||||
| Basic EPS | $ 91.56 | $ -16.24 | $ -12.44 | $ -20.90 | $ -23.75 |
| Diluted EPS | $ 90.22 | $ -16.24 | $ -12.44 | $ -20.90 | $ -23.75 |
| Weighted Average Shares Outstanding | 70.50M | 66.43M | 56.59M | 46.20M | 42.87M |
| Weighted Average Shares Outstanding (Diluted) | 71.55M | 66.43M | 56.59M | 46.20M | 42.87M |
Currency in DKK
